2012
DOI: 10.2174/157340312801215827
|View full text |Cite
|
Sign up to set email alerts
|

Evidence-Based Percutaneous Closure of the Left Atrial Appendage in Patients with Atrial Fibrillation

Abstract: Atrial fibrillation is the most common cardiac arrhythmia, and its prevalence is increasing. Cardioembolic stroke, most of the times secondary to thrombus formation in the left atrial appendage, is its most feared and life threatening consequence. Oral anticoagulation with vitamin-K-antagonists is currently the most used prophylaxis for stroke in patients with atrial fibrillation; unfortunately, its benefits are limited by a narrow therapeutic window and an increased risk for bleeding, making it often undesire… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
1
2

Year Published

2015
2015
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 65 publications
0
6
1
2
Order By: Relevance
“…In most literature, the LAA was described as “a long, tubular, hooked structure” of variable morphology and size[ 9 , 13 , 27 32 ]. However, our study detected substantially variable morphologies of the LAA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In most literature, the LAA was described as “a long, tubular, hooked structure” of variable morphology and size[ 9 , 13 , 27 32 ]. However, our study detected substantially variable morphologies of the LAA.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, the most established prophylaxis for stroke in atrial fibrillation is the dose-modulated oral anticoagulation with vitamin-K-antagonists, with warfarin being the most widely investigated drug[ 11 ]. Of note, it is often difficult to maintain long-term anticoagulation within a narrow therapeutic range partly because of regular laboratory monitoring of anticoagulation intensity, frequent dose adjustment and higher risks of bleeding during anticoagulation [ 13 , 14 ]. Patients with atrial fibrillation, high risk of stroke and contraindications to long-term oral administration of anticoagulants due to hemorrhage or other secondary adverse effects may be candidates for alternative treatment that combines high efficacy in stroke prevention and low hemorrhage risk.…”
Section: Introductionmentioning
confidence: 99%
“…Fibrilace síní je celosvětově nejčastější příčinou CMP. Prevence CMP tedy tvoří socioekonomicky vysoce relevantní složku péče o pacienty s FS [45]. Data týkající se perkutánních metod uzávěru LAA zatím nestačí k tomu, abychom tyto metody doporučovali jakýmkoli pacientům s výjimkou těch, kteří nemohou být dlouhodobě léčeni perorálními antikoagulancii.…”
Section: Diskuseunclassified
“…Nevertheless, financial problems of the manufacturer and a significant rate of adverse events, as mentioned earlier, led to discontinuation of the device in 2006. 37 …”
Section: Percutaneous Laa Closure: Endovascular Approachmentioning
confidence: 99%